KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
72 hedge funds and large institutions have $121M invested in Kinnate Biopharma Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 28 closing their positions.
Holders
72
Holders Change
+1
Holders Change %
+1.41%
% of All Funds
1.14%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
29
Increased
12
Reduced
23
Closed
28
Calls
$72K
Puts
$6K
Net Calls
+$66K
Net Calls Change
-$137K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$24.3M |
2 |
FCMV
2
Foresite Capital Management V
Larkspur,
California
|
$10.7M |
3 |
3
Millennium Management
New York
|
$2.73M |
4 |
4
Acadian Asset Management
Boston,
Massachusetts
|
$1.3M |
5 |
5
Renaissance Technologies
New York
|
$1.02M |